These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10543747)

  • 21. The continuing evolution of antiviral therapy for recurrent genital herpes: 1-day patient-initiated treatment with famciclovir.
    Aoki FY
    Herpes; 2007 Dec; 14(3):62-5. PubMed ID: 18371288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs.
    Bourne N; Ireland J; Stanberry LR; Bernstein DI
    Antiviral Res; 1999 Jan; 40(3):139-44. PubMed ID: 10027648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention.
    Thurman AR; Doncel GF
    Int J STD AIDS; 2012 Sep; 23(9):613-9. PubMed ID: 23033511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
    Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models.
    Valencia F; Veselenak RL; Bourne N
    Methods Mol Biol; 2013; 1030():315-26. PubMed ID: 23821278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclovir treatment of experimental genital herpes simplex virus infections.
    Kern ER
    Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs.
    Harrison CJ; Stanberry LR; Bernstein DI
    Antiviral Res; 1991 May; 15(4):315-22. PubMed ID: 1659313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genital herpes.
    Garland SM; Steben M
    Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1098-110. PubMed ID: 25153069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA immunization against experimental genital herpes simplex virus infection.
    Bourne N; Stanberry LR; Bernstein DI; Lew D
    J Infect Dis; 1996 Apr; 173(4):800-7. PubMed ID: 8603957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
    Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
    J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig.
    Landry ML; Lucia HL; Hsiung GD; Pronovost AD; Dann PR; August MJ; Mayo DR
    Am J Med; 1982 Jul; 73(1A):143-50. PubMed ID: 6285705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection.
    Friebe A; Siegling A; Weber O
    J Microbiol Immunol Infect; 2018 Oct; 51(5):587-592. PubMed ID: 28711432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of mucocutaneous presentations of herpes simplex virus infections.
    Nikkels AF; Pièrard GE
    Am J Clin Dermatol; 2002; 3(7):475-87. PubMed ID: 12180895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections.
    ACOG Committee on Practice Bulletins--Gynecology
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1111-8. PubMed ID: 15516420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.